← Back to headlines
Aprea Therapeutics and PolyPid Announce Q2 Earnings
Aprea Therapeutics reported a GAAP EPS of -$0.07, surpassing estimates by $0.16, while PolyPid announced a GAAP EPS of -$0.35, beating expectations by $0.03.
12 Aug, 12:32 — 12 Aug, 12:32
Sources
Showing 1 of 1 sources
